Pharmaceuticals, Biotechnology and Life Sciences
TORONTO and CHICAGO, May 24, 2022 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) has been informed by medac, a…
–NGM707, NGM Bio’s most advanced myeloid reprogramming antibody product candidate, will be showcased in the third of a four-part series…
– The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of…
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 24, 2022 Cambridge,…
SEATTLE, May 24, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development…
TORONTO, May 24, 2022 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services…
Leuven, BELGIUM, Boston, MA, US – MAY 24, 2022 – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next…
WOBURN, Mass., May 24, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of…
Results from an investigational Phase 3 PHALCON-EE trial demonstrating superior healing at week 2 in patients with LA Grade C/D…
Cranbury, NJ, May 24, 2022 (GLOBE NEWSWIRE) — Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare…